D. Western Therapeutics Institute (TSE:4576) Change In Receivables: 円0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4576 D. Western Therapeutics Institute Inc TSE:4576
39 GF Score
Price 円89.00
GF Value 円44.57
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute Change In Receivables?

D. Western Therapeutics Institute TSE:4576 +1.14% 39 Change In Receivables is 円0.0 Mil as of Jun. 2026. GuruFocus rates TSE:4576 with a GF Score™ of 39/100 and a GF Value™ of 円44.57 (Significantly Overvalued). The stock has 4 warning signs investors should review.

D. Western Therapeutics Institute's change in receivables for the quarter that ended in Jun. 2026 was 円0.0 Mil. It means D. Western Therapeutics Institute's Accounts Receivable stayed the same from Mar. 2026 to Jun. 2026 .

D. Western Therapeutics Institute's change in receivables for the fiscal year that ended in Dec. 2025 was 円30.5 Mil. It means D. Western Therapeutics Institute's Accounts Receivable declined by 円30.5 Mil from Dec. 2024 to Dec. 2025 .

D. Western Therapeutics Institute's Accounts Receivable for the quarter that ended in Jun. 2026 was 円96.2 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. D. Western Therapeutics Institute's liquidation value for the three months ended in Jun. 2026 was 円1,077.4 Mil.

D. Western Therapeutics Institute  (TSE:4576) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

D. Western Therapeutics Institute's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=96.182/0*91
=

2. In Ben Graham's calculation of liquidation value, D. Western Therapeutics Institute's accounts receivable are only considered to be worth 75% of book value:

D. Western Therapeutics Institute's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1581.537-640.522+0.75 * 96.182+0.5 * 128.437
=1,077.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Change In Receivables Related Terms

D. Western Therapeutics Institute Change In Receivables Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute Change In Receivables Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.80 -113.22 53.61 -7.88 30.52

D. Western Therapeutics Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4576
39GF Score
D. Western Therapeutics Institute Inc TSE:4576
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of 円0.0 Mil mean?
D. Western Therapeutics Institute (TSE:4576) has a Change In Receivables of 円0.0 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for D. Western Therapeutics Institute and its competitors.
Is D. Western Therapeutics Institute's Change In Receivables too high?
D. Western Therapeutics Institute's current Change In Receivables is 円0.0 Mil. Overall, D. Western Therapeutics Institute has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's Change In Receivables compare to VRTX and REGN?
D. Western Therapeutics Institute's Change In Receivables of 円0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Change In Receivables is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Significantly Overvalued. The stock's GF Value™ is 円44.57, compared to a current price of 円89.00 — trading 99.7% above its estimated fair value. The current Change In Receivables is 円0.0 Mil. D. Western Therapeutics Institute's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current Change In Receivables is 円0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円89.00 is trading 99.7% above its estimated GF Value™ of 円44.57. GuruFocus considers D. Western Therapeutics Institute to be Significantly Overvalued.

Key valuation signals for TSE:4576:

  • Change In Receivables: 円0.0 Mil
  • GF Value™: 円44.57 vs. price of 円89.00 (99.7% above fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

D. Western Therapeutics Institute Business Description

Other Exchanges 6DW:Germany
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
39GF Score

Get the complete analysis for TSE:4576

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円89.00
Price
円44.57
GF Value